1.47 0.12 (8.89%)

62.31% Fall from 52W High

652.9K XNAS Volume

XNAS 23 Apr, 2025 5:30 PM (EDT)



Insider Trading disclosures for Sunshine Biopharma Inc

The latest disclosure was made by Steve Slilaty in Sunshine Biopharma Inc where a trade of 100,000 Series B Preferred Stock done at an average price of $0.1 was reported to US exchanges on March 4, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Steve Slilaty Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.10 per share. 04 Mar 2024 100,000 130,000 - 0.1 10,000 Series B Preferred Stock
Slilaty Steve Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.10 per share. 08 Feb 2024 20,000 30,000 - 0.1 2,000 Series B Preferred Stock
Camille Sebaaly CFO/Secretary Purchase of securities on an exchange or from another person at price $ 0.76 per share. 30 Nov 2022 30,000 174,465 - 0.8 22,905 Common Stock
Camille Sebaaly CFO/Secretary Purchase of securities on an exchange or from another person at price $ 1.22 per share. 03 Jun 2022 25,000 144,465 - 1.2 30,500 Common Stock
Steve Slilaty Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.10 per share. 18 Feb 2022 990,000 10,000 - 0.1 99,000 Series B Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures